Crumly & Associates Inc. Amgen Inc Transaction History
Crumly & Associates Inc.
- $318 Million
- Q3 2024
A detailed history of Crumly & Associates Inc. transactions in Amgen Inc stock. As of the latest transaction made, Crumly & Associates Inc. holds 970 shares of AMGN stock, worth $267,157. This represents 0.1% of its overall portfolio holdings.
Number of Shares
970
Previous 872
11.24%
Holding current value
$267,157
Previous $272,000
14.71%
% of portfolio
0.1%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding AMGN
# of Institutions
3,080Shares Held
404MCall Options Held
7.56MPut Options Held
7.16M-
Vanguard Group Inc Valley Forge, PA52.4MShares$14.4 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.7 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.07 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.05 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$3.93 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $147B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...